Tag: MPS

Integral Molecular Enters Into Exclusive Antibody License With Seismic Therapeutic

Philadelphia – Integral Molecular, a leading biotech company specializing in antibody discovery against undruggable protein targets, announced today that it has entered into an […]

Webinar presented by Integral Molecular and Fierce Biotech – Conquering Undruggable Targets to Obtain Preclinical Antibodies

Thursday, September 14, 2023 8 am PT, 11 am ET, 17:00 CET Watch the webinar Despite the remarkable growth of antibody-based therapies in recent […]